Efonidipine
- Generic Name
- Efonidipine
- Drug Type
- Small Molecule
- Chemical Formula
- C34H38N3O7P
- CAS Number
- 111011-63-3
- Unique Ingredient Identifier
- 40ZTP2T37Q
Overview
Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels . It has also been studied in atherosclerosis and acute renal failure . This drug is also known as NZ-105, and several studies have been done on its pharmacokinetics in animals .
Background
Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels . It has also been studied in atherosclerosis and acute renal failure . This drug is also known as NZ-105, and several studies have been done on its pharmacokinetics in animals .
Indication
用于治疗高血压和心绞痛。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.